e-therapeutics offers up its rapid screening technology in quest to find COVID-19 vaccine
Its “in silico”, or computer simulation platform has successfully found active compounds capable of protecting human cells in influenza
Company
e-Therapeutics PLC
LON:ETX
e-Therapeutics PLC is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines. The company has developed and validated a powerful computational approach to drug discovery, leveraging our industry-leading expertise in network biology to fully capture and interrogate human disease complexity. e-Therapeutics' multi-disciplinary team builds computational models of biological functions to transform the search for new medicines, interventions, mechanisms and genetic support.
153 stories · page 3 of 8
e-therapeutics "at an important inflexion point"
The COVID-19 pandemic is not expected to materially alter the assumptions included in the group's budget
Former Silence boss takes over at e-Therapeutics in board overhaul; launches £1.6mln placing
Mortazavi will take up the role of executive chairman with Michael Bretherton joining as new independent non-executive
E-Therapeutics making good progress says chief executive
In August, it also announced a collaboration with an unnamed pharma major for a project looking at brain conditions
e-therapeutics teams up with a top-five pharma company for neurodegenerative diseases project
The 12-month tie-up with the unnamed drug giant will showcase the research group's network-driven drug discovery approach
Archive
Proactive news snapshot: Digitalbox, Seeing Machines, Alba Minerals Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
New tool from e-Therapeutics will analyse genomics of type-2 diabetes patients to find new drugs
A new contract extends last December's agreement with Novo Nordisk for another six months to June 2020
Archive
Small cap movers: Junior miners cash in on gold price spike
A look back at some of this week's more interesting stories from London's junior market
Archive
Proactive news snapshot: Thor Mining, Kibo Energy, Minds + Machines Group, Xtract Resources ...
A glance at some of the day's highlights from the Proactive Investors newswire
e-Therapeutics eyes further partnerships and possibly M&A to fully exploit its potential
Its most significant landmark of the year just gone was a collaboration with Danish multi-national Novo Nordisk focusing on type-2 diabetes
Investments and investor services
FTSE 100 closes higher despite lack of catalysts
Footsie finished up around 49 points at 7,183, while the FTSE 250 finished up nearly 32 points at 19,443
Archive
Direct Line to report higher 2018 profits despite large weather-related claims
The day ahead includes full year results from Direct Line and GVC along with a trading update from Ashtead
Archive
Insurance will be the corporate key in coming week, though US jobs data should be biggest draw
The Week Ahead brings updates from the likes of Aviva, Direct Line, L&G and Admiral, while investors can also bet on Paddy Power Betfair and GVC Holdings
Archive
Proactive news snapshot: Avacta, ValiRx, Minds + Machines Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Pressure Technologies steps on the gas after agreeing to sell its alternative energy division
A look at the day's major movers, including Local Shopping REIT, Just Group, Photo-Me, Lb-Shell, Avacta and ValiRx
Danish drugs giant Novo Nordisk to use e-Therapeutics’ technology in search for new diabetes treatments
e-Therapeutics will be reimbursed for its work under this collaboration and Novo Nordisk has the option to license relevant IP generated under the collaboration
Investments and investor services
FTSE 100 closes lower as UK Prime Minister pulls plug on key Brexit vote
The UK premier index finished down around 56 points at 6,721 on Monday
Archive
Proactive news snapshot: Strategic Minerals, Kodal Minerals, e-Therapeutics, Ceres Power …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Boku Inc sinks as it buys loss-making company
A look at the day's major movers, including Metals Exploration, Strategic Minerals, Challenger Acquisitions, Gresham Technologies and Countrywide
e-Therapeutics and C4x Discovery team up to find new Parkinson’s treatments
By combining both of their technologies, the companies think they can identify better treatments for Parkinson’s disease